日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Collaboration for new therapies: maximizing health and innovation

合作开发新疗法:最大限度地提高健康和创新能力

Mestre-Ferrandiz, Jorge; Meulien, Pierre; Ostwald, Dennis A; Acha, Virginia

Diagnostic criteria for apathy in neurocognitive disorders

神经认知障碍中冷漠的诊断标准

Miller, David S; Robert, Philippe; Ereshefsky, Larry; Adler, Lawrence; Bateman, Daniel; Cummings, Jeff; DeKosky, Steven T; Fischer, Corinne E; Husain, Masud; Ismail, Zahinoor; Jaeger, Judith; Lerner, Alan J; Li, Abby; Lyketsos, Constantine G; Manera, Valeria; Mintzer, Jacobo; Moebius, Hans J; Mortby, Moyra; Meulien, Didier; Pollentier, Stephane; Porsteinsson, Anton; Rasmussen, Jill; Rosenberg, Paul B; Ruthirakuhan, Myuri T; Sano, Mary; Zucchero Sarracini, Carla; Lanctôt, Krista L

Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials

以饮酒风险水平作为酒精药物治疗试验结果的评估:3项随机临床试验的二次分析

Falk, Daniel E; O'Malley, Stephanie S; Witkiewitz, Katie; Anton, Raymond F; Litten, Raye Z; Slater, Megan; Kranzler, Henry R; Mann, Karl F; Hasin, Deborah S; Johnson, Bankole; Meulien, Didier; Ryan, Megan; Fertig, Joanne

The Innovative Medicines Initiative -10 Years of Public-Private Collaboration

创新药物计划——公私合作十年

Laverty, Hugh; Meulien, Pierre

Global implementation of genomic medicine: We are not alone

全球基因组医学应用:我们并非孤军奋战

Manolio, Teri A; Abramowicz, Marc; Al-Mulla, Fahd; Anderson, Warwick; Balling, Rudi; Berger, Adam C; Bleyl, Steven; Chakravarti, Aravinda; Chantratita, Wasun; Chisholm, Rex L; Dissanayake, Vajira H W; Dunn, Michael; Dzau, Victor J; Han, Bok-Ghee; Hubbard, Tim; Kolbe, Anne; Korf, Bruce; Kubo, Michiaki; Lasko, Paul; Leego, Erkki; Mahasirimongkol, Surakameth; Majumdar, Partha P; Matthijs, Gert; McLeod, Howard L; Metspalu, Andres; Meulien, Pierre; Miyano, Satoru; Naparstek, Yaakov; O'Rourke, P Pearl; Patrinos, George P; Rehm, Heidi L; Relling, Mary V; Rennert, Gad; Rodriguez, Laura Lyman; Roden, Dan M; Shuldiner, Alan R; Sinha, Sukdeb; Tan, Patrick; Ulfendahl, Mats; Ward, Robyn; Williams, Marc S; Wong, John E L; Green, Eric D; Ginsburg, Geoffrey S

The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders

酒精临床试验计划 (ACTIVE):旨在评估酒精使用障碍药物研发中重要且突出的问题,并以此作为评估目标和目的。

Anton, Raymond F; Litten, Raye Z; Falk, Daniel E; Palumbo, Joseph M; Bartus, Raymond T; Robinson, Rebecca L; Kranzler, Henry R; Kosten, Thomas R; Meyer, Roger E; O'Brien, Charles P; Mann, Karl; Meulien, Didier

A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone

一项为期 24 周、多中心、开放标签、随机研究,旨在比较接受奥氮平、喹硫平或利培酮治疗的精神分裂症患者葡萄糖代谢的变化。

Newcomer, John W; Ratner, Robert E; Eriksson, Jan W; Emsley, Robin; Meulien, Didier; Miller, Frank; Leonova-Edlund, Julia; Leong, Ronald W; Brecher, Martin

Identification of chromosomally integrated TOL DNA in cured derivatives of Pseudomonas putida PAW1

在已治愈的恶臭假单胞菌PAW1衍生物中鉴定染色体整合的TOL DNA

Meulien, P; Broda, P

Physical mapping of TOL plasmids pWWO and pND2 and various R plasmid-TOL derivatives from Pseudomonas spp

对假单胞菌属的TOL质粒pWWO和pND2以及各种R质粒-TOL衍生物进行物理定位

Lehrbach, P R; Ward, J; Meulien, P; Broda, P